Questions over ghostwriting in drug industry
By Ewen Callaway Journal articles on hormone replacement therapy (HRT) ghostwritten by medical writers employed by the pharmaceutical industry serially understated the treatment's risks and promoted unapproved uses, according to an analysis of industry documents. The analysis, published September 7 in the journal PLoS Medicine , is based on some 1,500 e-mails, contracts and other documents made ...
Read more...
Discovery Rule Exception in Hormone Replacement Cases Ruled a Jury Question
Restoring 1,000 hormone replacement therapy mass tort cases to the Philadelphia Common Pleas Court's caseload, the Pennsylvania Superior Court ruled it is a question of fact, not of law, whether the plaintiffs could have known at the time of their diagnoses with breast cancer that alleged cause of their cancer was their HRT prescriptions.
Read more...
|
